author-photo

Shirin Khambata-Ford

Bristol-Myers Squibb

34

Papers

5889

Citations

Citation Trend

Filter By

Papers (34) Sort By

Journal Conference Others

Activity and tolerance of biweekly CapeOx-cetuximab in 1st line therapy of metastatic colorectal cancer (mCRC): Relation to K-ras mutation status

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
K-Ras mutation (mut), EGFR-related, and exploratory markers as response predictors of cetuximab in first-line advanced NSCLC: Retrospective analyses of the BMS099 trial

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (18)
High epiregulin (EREG) gene expression plus K-ras wild-type (WT) status as predictors of cetuximab benefit in the treatment of advanced colorectal cancer (ACRC): Results from NCIC CTG CO.17—A phase III trial of cetuximab versus best supportive care (BSC)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (37)
Association of CD133 polymorphisms and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with either first-line 5-FU + bevacizumab (BV) or second-line irinotecan (IR)/cetuximab (CB) or IR alone

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer.

2014 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (61)
Validation of Companion Diagnostic for Detection of Mutations in Codons 12 and 13 of the KRAS Gene in Patients with Metastatic Colorectal Cancer: Analysis of the NCIC CTG CO.17 Trial

2013 Archives of Pathology & Laboratory Medicine
Show All
- Source
- Cite
- Save
Citations (25)
Comparison of KRAS genotype: therascreen assay vs. LNA-mediated qPCR clamping assay.

2013 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Correlation between Gene Expression of IGF-1R Pathway Markers and Cetuximab Benefit in Metastatic Colorectal Cancer

2012 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (28)
9089 POSTER Exploratory Predictive Biomarker Assessment in the BMS099 Study of Cetuximab in NSCLC

2011 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
The cetuximab experience: developing predictive biomarkers in oncology

2011 Personalized Medicine
Show All
- Source
- Cite
- Save
Citations (1)